Similar Papers

Paper Title
Journal
Date
Author
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units
Roberto Scicali ... Salvatore Piro
Nutrition, Metabolism and Cardiovascular Diseases | VOL. 31
Roberto Scicali, et. al.Roberto Scicali ... Salvatore Piro
19 Aug 2021
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units.
Roberto Scicali ... Salvatore Piro
Biomedicines | VOL. 10
Roberto Scicali, et. al.Roberto Scicali ... Salvatore Piro
15 Jul 2022
The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia
Martine Paquette ... Alexis Baass
Journal of Clinical Lipidology | VOL. 11
Martine Paquette, et. al.Martine Paquette ... Alexis Baass
02 Feb 2017
Statin Intolerance and Noncompliance: An Empiric Approach
Scott M Grundy ... Gloria L Vega
The American Journal of Medicine | VOL. 135
Scott M Grundy, et. al.Scott M Grundy ... Gloria L Vega
28 Oct 2021
View more papers

More From: Atherosclerosis

Paper Title
Journal
Date
Author
Editorial Board
-
Atherosclerosis | VOL. 401
--
01 Feb 2025
RNA Splicing of the STAT3 by PCBP1 Promotes Vulnerable Plaque Formation via Macrophage-like Phenotype Modulation of Vascular Smooth Muscle Cell
Guobin Cheng ... Xiaoyang Li
Atherosclerosis | VOL. -
Guobin Cheng, et. al.Guobin Cheng ... Xiaoyang Li
01 Feb 2025
Interaction between chronic kidney disease and atrial fibrillation on incident stroke and all-cause mortality: Matched cohort study of 49,594 patients
David Ray Chang ... Chin-Chi Kuo
Atherosclerosis | VOL. 401
David Ray Chang, et. al.David Ray Chang ... Chin-Chi Kuo
01 Feb 2025
Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank.
Kyle Gibson ... Ben O Petrazzini
Atherosclerosis | VOL. 401
Kyle Gibson, et. al.Kyle Gibson ... Ben O Petrazzini
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.